Symposia: Bone Marrow Failure: Acquired
Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acquired Marrow Failure Syndromes, Biological therapies, Antibody Therapy, adult, Translational Research, Bone Marrow Failure Syndromes, Non-Biological therapies, elderly, Clinical Research, Aplastic Anemia, Genetic Disorders, Chemotherapy, Diseases, Immune Disorders, immunodeficiency, real-world evidence, Therapies, registries, Infusion, young adult , Monoclonal Antibody Therapy, Study Population, Human, Transplantation
Type: Oral
Hematology Disease Topics & Pathways:
Research, Acquired Marrow Failure Syndromes, Biological therapies, Antibody Therapy, adult, Translational Research, Bone Marrow Failure Syndromes, Non-Biological therapies, elderly, Clinical Research, Aplastic Anemia, Genetic Disorders, Chemotherapy, Diseases, Immune Disorders, immunodeficiency, real-world evidence, Therapies, registries, Infusion, young adult , Monoclonal Antibody Therapy, Study Population, Human, Transplantation
Monday, December 11, 2023: 10:30 AM-12:00 PM
Room 6DE
(San Diego Convention Center)
Moderators:
Taha Bat, MD,
and
Swapna Thota, MD, University of Tennessee Health Science Center
Disclosures:
Bat: Alexion pharma: Membership on an entity's Board of Directors or advisory committees.
In this session we will focus on two diseases - immune AA and VEXAS. We will focus on the pathophysiology underpinning these disease and possible predictors for outcomes. Therapy will be discussed, with a particular emphasis on hematopoietic stem cell transplant.
10:45 AM
11:00 AM
11:15 AM
11:45 AM
See more of: Oral and Poster Abstracts
*signifies non-member of ASH